1 / 5
Febuxostat CAS 144060-53-7 is a selective xanthine oxidase inhibitor. It inhibits the activity of xanthine oxidase, reducing the conversion of hypoxanthine and xanthine to uric acid, thereby lowering serum uric acid levels. It is suitable for the treatment of hyperuricemia in patients with chronic gout, especially for those who are intolerant to allopurinol or have poor efficacy with allopurinol.
Function: Febuxostat is a xanthine oxidase (XO) inhibitor that is suitable for the long-term treatment of hyperuricemia with gout symptoms.
| Product name | Febuxostat |
| CAS No. | 144060-53-7 |
| Purity | 99% |
| Appearance | White powder |
| Application | Healthcare |
| Storage | Store in a closed container in a cool and dry place, below 5ºC. |
| Retest Date | 2 years |
Remarks:


Certified by cGMP, ISO9001, HACCP, ISO22000, FSSC22000, EOS, NOP, Kosher, HALAL, etc.